Masimo Executive and Leadership Team

Katie Szyman, the Chief Executive Officer at Masimo, directs the company's overarching strategy and global operations. Szyman guides Masimo's mission to develop and manufacture innovative noninvasive patient monitoring technologies, medical devices, sensors, hospital automation, connectivity solutions, and telehealth platforms. Overseeing all business units, the Chief Executive Officer ensures alignment with the company's founding principles of improving patient outcomes and reducing healthcare costs. This leadership role involves driving market expansion and fostering innovation across all product lines, including the revolutionary Signal Extraction Technology pulse oximetry. By championing research and development, Katie Szyman ensures Masimo maintains its position as a leader in medical technology, impacting patient care in hospital and home healthcare settings globally. Szyman's executive oversight extends to all functional areas, ensuring operational excellence and sustained growth.

Tetsuro Maniwa, the President & Chief Executive Officer (Japan, China, Hong Kong, Taiwan, & South Korea) at Masimo, spearheads the company's strategic initiatives and operational execution across key Asian markets. Maniwa directs the expansion and market penetration of Masimo's innovative noninvasive patient monitoring technologies and medical devices within these vital regions. This leadership position involves cultivating strong relationships with healthcare providers and distributors to ensure widespread adoption of Masimo's solutions, including its proprietary Signal Extraction Technology pulse oximetry. By overseeing sales, marketing, and operational functions, Tetsuro Maniwa drives revenue growth and reinforces Masimo's commitment to improving patient care in Japan, China, Hong Kong, Taiwan, and South Korea. Maniwa's focus on regional market dynamics ensures Masimo's continued success and impact in diverse healthcare landscapes.

Michael Young, the Executive VP & Chief Financial Officer at Masimo, manages the company's financial health and strategic fiscal planning. Young oversees all financial operations, including accounting, treasury, financial reporting, and investor relations, ensuring robust fiscal management for Masimo's global activities. This executive VP role involves developing financial strategies that support the company's growth objectives and operational efficiency in manufacturing medical devices and patient monitoring technologies. By analyzing market trends and financial performance, Michael Young provides critical insights to guide executive decision-making and resource allocation. The Chief Financial Officer ensures compliance with all financial regulations and drives initiatives to optimize profitability and shareholder value. Young's leadership in finance underpins Masimo's ability to invest in groundbreaking research and expand its reach in hospital and home healthcare markets worldwide.

Fahad Alanazi, the President (Middle East, Turkey & Africa) at Masimo, leads the company's strategic growth and operational oversight across a significant global territory. Alanazi drives the market presence and adoption of Masimo's advanced noninvasive patient monitoring technologies and medical devices throughout the Middle East, Turkey, and Africa. This executive role involves building and managing key partnerships with healthcare institutions and stakeholders to deliver Masimo's innovative solutions, including its renowned pulse oximetry systems. By focusing on regional market needs and opportunities, Fahad Alanazi ensures the effective deployment of hospital automation and telehealth platforms, enhancing patient care standards. Alanazi's leadership is critical in expanding Masimo's footprint and impact in these dynamic and growing healthcare markets, contributing to improved patient outcomes.

Mustafa Marie, the Regional President, Vise Levant Africa (Turkey) at Masimo, directs the company's business operations and strategic development within a key geographic area. Marie oversees the sales, distribution, and market penetration of Masimo's cutting-edge noninvasive patient monitoring technologies and medical devices across Levant, Africa, and Turkey. This critical leadership function involves fostering strong relationships with healthcare professionals and organizations to ensure the effective implementation of Masimo's solutions, including its advanced pulse oximetry and telehealth platforms. By understanding and addressing the unique healthcare needs of the region, Mustafa Marie drives market growth and enhances patient care standards. Marie's efforts are instrumental in expanding Masimo's reach and impact, reinforcing its commitment to improving lives through innovative medical technology.

Richard Fishel, the President, Worldwide OEM Business & Strategic Business Development at Masimo, architects the company's global original equipment manufacturer (OEM) strategy and cultivates key strategic partnerships. Fishel drives the integration of Masimo's pioneering noninvasive patient monitoring technologies and medical devices into a wide array of third-party products and platforms worldwide. This executive role involves identifying and securing new business opportunities, fostering innovation through collaboration, and expanding Masimo's technological reach across diverse industries. By focusing on strategic alliances and OEM agreements, Richard Fishel ensures Masimo's advanced solutions, including its proprietary pulse oximetry, are accessible to a broader global audience. Fishel's leadership in business development is crucial for Masimo's sustained growth and market leadership.

Matthew Anacone, the President, Sales & OEM(Americas & Worldwide) at Masimo, leads the company's comprehensive sales initiatives and OEM business development across the Americas and globally. Anacone directs the sales teams responsible for promoting and distributing Masimo's innovative noninvasive patient monitoring technologies, medical devices, and telehealth platforms. This executive position involves developing and executing sales strategies that drive revenue growth and expand market share for Masimo's product portfolio, including its industry-leading pulse oximetry. By fostering strong client relationships and overseeing OEM partnerships, Matthew Anacone ensures Masimo's solutions effectively reach healthcare providers and consumers worldwide. Anacone's sales leadership is pivotal in achieving Masimo's mission of improving patient outcomes and reducing healthcare costs.

Timothy Benner, the Executive VP & Chief Marketing & Strategy Officer at Masimo, shapes the company's global brand presence and long-term strategic direction. Benner oversees all marketing initiatives, brand management, and corporate strategy development, ensuring Masimo's innovative medical technologies and patient monitoring solutions are effectively communicated to global markets. This executive role involves identifying emerging market trends, defining competitive positioning, and driving strategic planning to support Masimo's mission of improving patient outcomes. By leading marketing efforts and strategic foresight, Timothy Benner ensures Masimo's proprietary Signal Extraction Technology pulse oximetry and other advanced devices maintain their market leadership. Benner's strategic vision and marketing expertise are crucial for Masimo's continued innovation and global expansion.